# Pacira BioSciences, Inc.: filings

PCRX · Nasdaq · CIK 1396814 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pcrx.md) · [Financials](/companies/pcrx/financials.md) · [Filings](/companies/pcrx/filings.md) · [Insiders](/companies/pcrx/insiders.md)

## Reports and events: 320 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 632, 8-K 203, 144 70, SC 13G/A 58, 3 52, 10-Q 47, DEFA14A 23, CT ORDER 20, SC 13D/A 17, SC 13G 17, 10-K 16, DEF 14A 14, S-8 13, DFAN14A 11, UPLOAD 9, 4/A 8, ARS 7, CORRESP 7, S-1/A 6, SCHEDULE 13G 6, 8-K/A 5, SC 13D 5, 424B5 4, SCHEDULE 13D/A 4, SCHEDULE 13G/A 4, SC TO-T/A 4, EFFECT 3, FWP 3, SC TO-C 3, 424B4 2, 5 2, DEFC14A 2, PRRN14A 2, S-1 2, SC TO-T 2, 8-A12B 1, CERTNAS 1, PREC14A 1, S-1MEF 1, S-3 1, S-3ASR 1, SC 14D9 1, SC14D9C 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 17:54 ET | [SCHEDULE 13D/A](/filings/0001104659-26-115589.md) | Ownership report, active investor, amended | 0001104659-26-115589 |
| 2026-10-08 | 09:24 ET | [8-K](/filings/0001104659-26-114571.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-114571 |
| 2026-08-04 | 16:30 ET | [10-Q](/filings/0001628280-26-052635.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052635 |
| 2026-08-04 | 16:03 ET | [8-K](/filings/0001628280-26-052527.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052527 |
| 2026-06-30 | 07:31 ET | [8-K](/filings/0001628280-26-046136.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-046136 |
| 2026-06-11 | 16:32 ET | [8-K](/filings/0001628280-26-042525.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-042525 |
| 2026-04-30 | 16:07 ET | [10-Q](/filings/0001628280-26-028871.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028871 |
| 2026-04-30 | 16:03 ET | [8-K](/filings/0001628280-26-028854.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-028854 |
| 2026-03-12 | 19:57 ET | [SCHEDULE 13D/A](/filings/0001011438-26-000180.md) | Ownership report, active investor, amended | 0001011438-26-000180 |
| 2026-02-26 | 16:16 ET | [10-K](/filings/0001628280-26-012297.md) | Annual report, period 2025-12-31 | 0001628280-26-012297 |
| 2026-02-26 | 16:02 ET | [8-K](/filings/0001628280-26-012238.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-012238 |
| 2026-01-28 | 08:01 ET | [8-K](/filings/0001628280-26-003717.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-003717 |
| 2026-01-08 | 16:02 ET | [8-K](/filings/0001628280-26-001335.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001335 |
| 2026-01-02 | 12:18 ET | [SCHEDULE 13D/A](/filings/0001214659-26-000011.md) | Ownership report, active investor, amended | 0001214659-26-000011 |
| 2025-11-10 | 20:00 ET | [SCHEDULE 13D/A](/filings/0001214659-25-016174.md) | Ownership report, active investor, amended | 0001214659-25-016174 |
| 2025-11-06 | 16:13 ET | [10-Q](/filings/0001628280-25-050176.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050176 |
| 2025-11-06 | 16:04 ET | [8-K](/filings/0001628280-25-050145.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050145 |
| 2025-08-08 | 13:26 ET | [SCHEDULE 13D](/filings/0001962221-25-000003.md) | Ownership report, active investor | 0001962221-25-000003 |
| 2025-08-05 | 16:07 ET | [10-Q](/filings/0001396814-25-000102.md) | Quarterly report, period 2025-06-30 | 0001396814-25-000102 |
| 2025-08-05 | 16:01 ET | [8-K](/filings/0001396814-25-000100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000100 |
| 2025-07-10 | 07:35 ET | [8-K](/filings/0001396814-25-000093.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000093 |
| 2025-07-07 | 08:00 ET | [8-K](/filings/0001104659-25-065979.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-065979 |
| 2025-06-13 | 16:26 ET | [8-K](/filings/0001396814-25-000089.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001396814-25-000089 |
| 2025-05-08 | 16:07 ET | [10-Q](/filings/0001396814-25-000061.md) | Quarterly report, period 2025-03-31 | 0001396814-25-000061 |
| 2025-05-08 | 16:06 ET | [8-K](/filings/0001396814-25-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000060 |
| 2025-04-29 | 16:08 ET | [DEF 14A](/filings/0001104659-25-041219.md) | Proxy statement, period 2024-06-10 | 0001104659-25-041219 |
| 2025-04-22 | 08:59 ET | [8-K](/filings/0001396814-25-000055.md) | 8.01 Other events | 0001396814-25-000055 |
| 2025-04-07 | 16:59 ET | [8-K](/filings/0001396814-25-000051.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000051 |
| 2025-03-14 | 17:28 ET | [8-K](/filings/0001396814-25-000048.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001396814-25-000048 |
| 2025-02-27 | 16:15 ET | [10-K](/filings/0001396814-25-000041.md) | Annual report, period 2024-12-31 | 0001396814-25-000041 |
| 2025-02-27 | 16:06 ET | [8-K](/filings/0001396814-25-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000039 |
| 2025-01-30 | 08:01 ET | [8-K](/filings/0001396814-25-000022.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000022 |
| 2025-01-21 | 08:05 ET | [8-K](/filings/0001396814-25-000017.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-25-000017 |
| 2025-01-10 | 08:01 ET | [8-K](/filings/0001396814-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-25-000011 |
| 2024-11-06 | 16:01 ET | [10-Q](/filings/0001396814-24-000141.md) | Quarterly report, period 2024-09-30 | 0001396814-24-000141 |
| 2024-11-06 | 16:00 ET | [8-K](/filings/0001396814-24-000140.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001396814-24-000140 |
| 2024-10-21 | 08:04 ET | [8-K](/filings/0001396814-24-000129.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-24-000129 |
| 2024-09-27 | 08:02 ET | [8-K](/filings/0001396814-24-000124.md) | 5.02 Departure or appointment of officers or directors | 0001396814-24-000124 |
| 2024-09-09 | 16:02 ET | [8-K](/filings/0001396814-24-000120.md) | 8.01 Other events | 0001396814-24-000120 |
| 2024-08-09 | 15:23 ET | [8-K](/filings/0001396814-24-000103.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001396814-24-000103 |
| 2024-07-30 | 16:02 ET | [10-Q](/filings/0001396814-24-000098.md) | Quarterly report, period 2024-06-30 | 0001396814-24-000098 |
| 2024-07-30 | 16:01 ET | [8-K](/filings/0001396814-24-000097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001396814-24-000097 |
| 2024-06-13 | 17:14 ET | [8-K](/filings/0001396814-24-000057.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001396814-24-000057 |
| 2024-05-14 | 16:00 ET | [8-K](/filings/0001104659-24-061135.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-061135 |
| 2024-05-08 | 16:13 ET | [8-K](/filings/0001104659-24-058675.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-058675 |
| 2024-05-07 | 16:02 ET | [10-Q](/filings/0001396814-24-000045.md) | Quarterly report, period 2024-03-31 | 0001396814-24-000045 |
| 2024-05-07 | 16:01 ET | [8-K](/filings/0001396814-24-000044.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001396814-24-000044 |
| 2024-04-22 | 16:16 ET | [DEF 14A](/filings/0001104659-24-049997.md) | Proxy statement, period 2024-06-11 | 0001104659-24-049997 |
| 2024-02-29 | 15:33 ET | [10-K](/filings/0001396814-24-000030.md) | Annual report, period 2023-12-31 | 0001396814-24-000030 |
| 2024-02-29 | 08:03 ET | [8-K](/filings/0001396814-24-000026.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001396814-24-000026 |

Page 1 of 7. [Older](/companies/pcrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:40 ET. No prices; not investment advice.